Back to search

Article

Lysophosphatidic acid (LPA)-antibody (504B3) validation by free-solution assay and interferometry identifies off-target binding

2020-10-05

Abstract excerpt

Antibody specificity and sensitivity is required in basic and clinical research for ensuring scientific rigor and reproducibility, while off-target cross-reactivity could generate erroneous conclusions. Lysophosphatidic acid (LPA) is a bioactive lipid being targeted clinically by antibody strategies. Here, we reexamined binding properties of a commercially available monoclonal antibody (504B3) reported as specific...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
72ae80a6-f2a3-595e-b37c-febf8e37fdab
DOI
10.1101/2020.10.05.327122
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lysophosphatidic acid (LPA)-antibody (504B3) validation by free-solution assay and interferometry identifies off-target bindingDOI 10.1101/2020.10.05.327122
Select a neighboring publication to make it the new centre.